FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileSolventum Corporation
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SOLV
Solventum Corporation Stock AnalysisComprehensive stock analysis for Solventum Corporation (SOLV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSOLV
SOLV
Solventum Corporation
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SOLV
  1. Home
  2. Stocks
  3. Solventum Corporation

Solventum Corporation

🇺🇸SOLV•NYSE

Solventum Corporation

🇺🇸SOLV•NYSE
Market cap
$15.07B
Sentiment

Your view on SOLV

Mkt Cap
$15.07B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Solventum Corporation

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Bryan C. Hanson
Headquarters
US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Bryan C. Hanson
Headquarters
US
Description

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.

The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.

The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms.

The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Solventum Corporation from FRC's valuation model, read against the market price. SOLV last traded at $88.65, 99.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Solventum Corporation. Starting points for Solventum Corporation: P/E 99.8, EPS $0.91, beta 0.75 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Solventum Corporation. Solventum Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Solventum Corporation. Trailing twelve-month EPS for Solventum Corporation stands at $0.91. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$85.60

average of 10 firms, last 12 months

 

$85.60

Low $35.00

Median $94.50

High $113.00

 

Analyst Ratings

Buy8 firms, last 12 months
  • Strong Buy0
  • Buy7
  • Hold1
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$1.77$1.77$7.25$7.60
Low estimate$1.55$1.51$7.14$7.30
High estimate$1.90$1.90$7.51$7.83
No. of analysts86910
Year-ago EPS$1.57$1.48$8.88—
Growth+12.9%+19.3%-18.4%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$2.09B$2.08B$8.25B$8.57B
Low estimate$2.06B$2.05B$8.20B$8.49B
High estimate$2.10B$2.10B$8.39B$8.72B
No. of analysts851111
Year-ago revenue$2.00B$2.01B$8.32B—
Growth+4.4%+3.8%-0.9%—
Recent analyst actions15 rating and price-target changes, latest Nov 6, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Solventum Corporation. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold SOLV20 companies · 8 funds
Compare SOLV with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BAXBaxter International Inc.Medical - Instruments & Supplies$13.2B
  • BDXBecton, Dickinson and CompanyMedical - Instruments & Supplies$59.0B
  • CNVVFConvaTec Group PlcMedical - Instruments & Supplies$7.1B
  • COOThe Cooper Companies, Inc.Medical - Instruments & Supplies$11.8B
  • HSICHenry Schein, Inc.Medical - Distribution$9.4B
  • ICUIICU Medical, Inc.Medical - Instruments & Supplies$4.5B
  • MMSIMerit Medical Systems, Inc.Medical - Instruments & Supplies$5.2B
  • NVSTEnvista Holdings CorpMedical - Instruments & Supplies$3.9B

More Medical - Instruments & Supplies companies

  • WSTWest Pharmaceutical Services, Inc.NYSE$29.1B
  • XRAYDENTSPLY SIRONA Inc.NASDAQ$1.8B
  • YBGJYubo International Biotech LimitedOTC$1M
  • ZJYLJin Medical International Ltd.NASDAQ$28M
  • SHWGYShandong Weigao Group Medical Polymer Company LimitedOTC$3.0B
  • SMTISanara MedTech Inc.NASDAQ$301M
  • SOAGYSartorius AGOTC$82.3B
  • SRTOYSartorius Stedim Biotech S.A.OTC$209.8B
  • SSSGYSartorius AGOTC$15.8B
  • STAASTAAR Surgical CompanyNASDAQ$1.3B
  • STSSSharps Technology, Inc.NASDAQ$54M
  • STVNStevanato Group S.p.A.NYSE$4.2B

ETFs holding Solventum Corporation

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.02%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
  • VBVanguard Small-Cap ETF$76.9B in assets0.15%
  • RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
  • CSDInvesco S&P Spin-Off ETF$214M in assets4.60%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets2.25%
  • DUSADavis Select U.S. Equity ETF$1.3B in assets2.17%
  • DWLDDavis Select Worldwide ETF$584M in assets1.98%

Largest holders first, then the funds most concentrated in SOLV.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Solventum Corporation, and how their positions are changing. At a $15.07B market value, institutional positions materially move Solventum Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Solventum Corporation executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Solventum Corporation. Solventum Corporation is a $15.07B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Solventum Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Solventum Corporation. Coverage tracks Solventum Corporation within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Solventum Corporation.

SOLV Analysis
Good
Past3
Growth2
Health3
Profit4
Value3

News

Latest Market News